CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer: apersonalized molecular surgical therapy EMBO MOLECULAR MEDICINE Tang, H., Shrager, J. B. 2016; 8 (2): 83-85

View details for Web of Science ID 000369727900004

View details for PubMedCentralID PMC4734839